Home

Disease management

Depression, Schizophrenia

Early intervention services have the potential to improve the success of treatment and social functioning for individuals with schizophrenia

Schizophrenia is a heterogenous, progressive and recurrent disease with multiple dimensions which...

Read time: 4 min

Congress highlights

Educating the patient aids effective treatment of migraine

Teaching the patient about their brain can truly make a difference in their engagement with...

Read time: 3 min

Congress highlights

Why is migraine the second most disabling disease worldwide?

Migraine affects all areas of life. Its sudden unpredictable onset with severe incapacitating...

Read time: 3 min

Congress highlights

Is chronic migraine a more chronic severe episodic migraine?

Migraine-associated genes, activation of specific brain regions and cervical nerves, and...

Read time: 3 min

Congress highlights

Top three articles from Headache: the Journal of Headache and Face Pain 2019

Are mothers with migraine more likely to have a baby with colic? What are the risk factors for new-...

Read time: 3 min

Congress highlights

Adherent to adherence – strategies in schizophrenia

Adherence to antipsychotic medication helps in achieving the best possible outcomes for patients...

Read time: 3 min

Congress highlights

Do men and women experience psychiatric disorders differently?

There are several known epidemiological differences between the genders in psychiatric disorders....

Read time: 3 min

Congress highlights

Distinguishing comorbidities from differential diagnoses in bipolar disorder

Making a diagnosis of bipolar disorder (BD) can be challenging — comorbid psychiatric...

Read time: 2 min

Social and cognitive interventions that improve outcomes for patients with psychosis

A 3-month critical time intervention service involving social workers and peer specialists to...

Read time: 3 min

Congress highlights

Motivating strategies to fight stigma

Stigma means exclusion, and is the largest barrier preventing people from seeking mental healthcare...

Depression, Bipolar

Read time: 3 min

Congress highlights

Inflammatory biomarkers in mood disorders and implications for treatment

Inflammation appears to play a role in the development of major depressive disorder (MDD) and...

Parkinson's Disease

Read time: 3 min

Congress highlights

The symptom spectrum of wearing-off in Parkinson’s disease

In a satellite symposium held at the 2019 EAN Congress, the speakers discussed the spectrum of...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country